Outcomes of patients aged ≥80 years with respiratory failure initially treated with non-invasive ventilation in European intensive care units before and during COVID-19 pandemic - 08/01/26
COVIP VIP2 study groups
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Non-invasive ventilation (NIV) has been commonly used to treat acute respiratory failure due to COVID-19. In this study we aimed to compare outcomes of older critically ill patients treated with NIV before and during the COVID-19 pandemic.
Methods |
We analysed a merged cohort of older adults admitted to intensive care units (ICUs) due to respiratory failure. Patients were enrolled into one of two prospective observational studies: before COVID-19 (VIP2—2018 to 2019) and admitted due to COVID-19 (COVIP—March 2020 to January 2023). The outcomes included: 30-day mortality, intubation rate and NIV failure (death or intubation within 30 days).
Results |
The final cohort included 1986 patients (1292 from VIP2, 694 from COVIP) with a median age of 83 years. NIV was used as a primary mode of respiratory support in 697 participants (35.1%). ICU admission due to COVID-19 was associated with an increased 30-day mortality (65.5% vs. 36.5%, HR 2.18, 95% CI 1.71 to 2.77), more frequent intubation (36.9% vs. 17.5%, OR 2.63, 95% CI 1.74 to 3.99) and NIV failure (76.2% vs. 45.3%, OR 4.21, 95% CI 2.84 to 6.34) compared to non-COVID causes of respiratory failure. Sensitivity analysis after exclusion of patients in whom life supporting treatment limitation was introduced during primary NIV confirmed higher 30-day mortality in patients with COVID-19 (52.5% vs. 23.4%, HR 2.64, 95% CI 1.83 to 3.80).
Conclusion |
The outcomes of patients aged ≥80 years treated with NIV during COVID-19 pandemic were worse compared then those treated with NIV in the pre-pandemic era.
Le texte complet de cet article est disponible en PDF.Keywords : COVID-19, Older patients, Intensive care unit, Non-invasive ventilation, Respiratory failure
Keywords : Medical and Health Sciences, Clinical Sciences
Plan
Vol 13 - N° 1
Article 82- 2023 Retour au numéro
Article précédent
- Broadening the Berlin definition of ARDS to patients receiving high-flow nasal oxygen: an observational study in patients with acute hypoxemic respiratory failure due to COVID-19
- Fleur-Stefanie L.I.M. van der Ven, Christel M.A. Valk, Siebe Blok, Michelle G. Brouwer, Dai Ming Go, Amanda Lokhorst, Pien Swart, David M.P. van Meenen, Frederique Paulus, Marcus J. Schultz, for the PRoAcTCOVID study investigators, E Aydeniz, P van de Berg, D C Bergmans, M Bevers, S den Boer, L S Boers, L D Bos, M Botta, L A Buiteman-Kruizinga, W Coene, M Delmte, Vincenzo Di Leo, D A Dongelmans, T P Dormans, L M Elting, A A Esmeijer, M G de Abreu, A R Girbes, M J de Graaff, D M Go, R L Goossen, H J Hansen, J J Haringman, L Hol, M W Hollmann, P L van der Heiden, J Horn, L E van Ingen, N P Juffermans, M A Kuiper, L J Kuipers, E Koornstra, A Lokhorst, S G Nijbroek, I Martin-Loeches, D M van Meenen, G Mazzinari, S Myatra, F Paulus, M Offermans, T Pisters, A Prins, P van Oosten, J Pillay, I M Purmer, A S Rezaee, T C D Rettig, O Roca, N M Rosenberg, N Schavemaker, A A Sciascera, M J Schultz, A Serpa Neto, G Shrestha, M E Sleeswijk, W Stilma, A C Strang, A C Spronk, P R Tuinman, A M Tsonas, C M A Valk, M Verboom, A P Vlaar, W H van der Ven, P van Velzen, E J Verhoef, T D Vermeulen, P van Vliet, J J Voorham, P H van der Voort, M van der Woude, N Yaali, J M Zandvliet, A R van Zanten, T Z van Zijl, S A Zonneveld
- Diaphragm function in patients with Covid-19-related acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation
- Melchior Gautier, Vincent Joussellin, Jacques Ropers, Lina El Houari, Alexandre Demoule, Thomas Similowski, Alain Combes, Matthieu Schmidt, Martin Dres
Bienvenue sur EM-consulte, la référence des professionnels de santé.